Compare OMER & FVRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OMER | FVRR |
|---|---|---|
| Founded | 1994 | 2010 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 628.9M | 754.2M |
| IPO Year | 2009 | 2019 |
| Metric | OMER | FVRR |
|---|---|---|
| Price | $12.52 | $17.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 10 |
| Target Price | $32.50 | ★ $32.60 |
| AVG Volume (30 Days) | ★ 4.4M | 969.8K |
| Earning Date | 11-13-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 139.40 |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $427,401,000.00 |
| Revenue This Year | N/A | $12.77 |
| Revenue Next Year | N/A | $5.67 |
| P/E Ratio | ★ N/A | $28.67 |
| Revenue Growth | N/A | ★ 12.68 |
| 52 Week Low | $2.95 | $17.32 |
| 52 Week High | $17.65 | $35.45 |
| Indicator | OMER | FVRR |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 25.64 |
| Support Level | $11.85 | $17.76 |
| Resistance Level | $16.14 | $18.65 |
| Average True Range (ATR) | 1.62 | 0.64 |
| MACD | -0.37 | -0.17 |
| Stochastic Oscillator | 43.31 | 0.50 |
Omeros Corp is a United States-based clinical-stage biopharmaceutical company engaged in discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting immunologic disorders including complement-mediated diseases, cancers, and addictive and compulsive disorders. The drug candidate in the pipeline of complement-targeted therapeutics is narsoplimab (OMS721), a proprietary, patented human monoclonal antibody targeting mannan-binding lectin-associated serine protease 2, the key activator of the lectin pathway of complement. Clinical development of narsoplimab is currently focused on hematopoietic stem cell transplant-associated thrombotic microangiopathy and immunoglobulin nephropathy.
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.